Antifungal and antibiofilm activities of selective serotonin reuptake inhibitors alone and in combination with fluconazole

belirlenmesidir. Objectives: Candida spp. are clinically important pathogens that cause difficulties for treatment by biofilm formation. Considering antifungal resistance rates and the limitations in the discovery of new antifungals, the antifungal and antibiofilm effects of various drugs used for different therapeutic purposes are becoming more important. The goal of our study was to determine the antifungal and antibiofilm effects of the selective serotonin reuptake inhibitors (SSRIs), namely sertraline (SRT), paroxetine (PRX), and fluoxetine (FLX) alone and in combination with fluconazole (FLC) against Candida spp. Materials and Methods: Twenty Candida spp. strains isolated from clinical samples from Ege University Hospital were identified by the Dalmau method and matrix-assisted laser desorption ionization time of flight mass spectrometry. The minimum inhibitory concentrations (MICs) of the SSRIs and FLC were detected by broth microdilution method. Synergistic interactions between the SSRIs and FLC were investigated by checkerboard assay. The antibiofilm effects of the SSRIs were determined by spectrophotometric microplate method. Results: Among the isolates, five different Candida spp. (C. albicans, C. glabrata, C. krusei, C. tropicalis, and C.parapsilosis) were identified. The MICs of the SSRIs ranged between 16-512 μg/mL. While SRT showed the highest antifungal effect, the antibiofilm efficacy of FLX was higher than that of the other agents. Moreover, FLX and PRX showed a synergistic effect with FLC in 13 and 19 isolates, respectively. Four isolates were strong biofilm producers while nine isolates were moderate biofilm producers. C. parapsilosis strains showed higher biofilm production than the other species. At MIC/2 concentration, FLX and SRT alone inhibited mature biofilms in six and five isolates, respectively, while PRX caused increases biofilm formation in seven isolates. Conclusion: This study revealed that MIC/2 concentrations of SSRIs could have antifungal and antibiofilm effects. SRT and FLX alone or in combination with antifungals may possibly have therapeutic potential for combating fungal infections.

[1]  J. Martinez-de-Oliveira,et al.  Anti-Candida activity of antidepressants sertraline and fluoxetine: effect upon pre-formed biofilms , 2018, Medical Microbiology and Immunology.

[2]  N. Gunde-Cimerman,et al.  Candida parapsilosis in domestic laundry machines , 2017, Medical mycology.

[3]  C. Rizzato,et al.  The synthetic killer peptide KP impairs Candida albicans biofilm in vitro , 2017, PloS one.

[4]  B. Cavalcanti,et al.  In vitro anti-Candida activity of selective serotonin reuptake inhibitors against fluconazole-resistant strains and their activity against biofilm-forming isolates. , 2017, Microbial pathogenesis.

[5]  Francisco Madariaga-Venegas,et al.  Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients , 2017, PloS one.

[6]  Anália Lourenço,et al.  Critical review on biofilm methods , 2017, Critical reviews in microbiology.

[7]  Siripen Pesee,et al.  In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm. , 2016, Medical mycology.

[8]  J. Udayalaxmi,et al.  Comparison Between Biofilm Production, Phospholipase and Haemolytic Activity of Different Species of Candida Isolated from Dental Caries Lesions in Children. , 2016, Journal of clinical and diagnostic research : JCDR.

[9]  Shuyuan Liu,et al.  Synergistic effect of fluconazole and doxycycline against Candida albicans biofilms resulting from calcium fluctuation and downregulation of fluconazole-inducible efflux pump gene overexpression. , 2014, Journal of medical microbiology.

[10]  Ronald N. Jones,et al.  Comparison of EUCAST and CLSI broth microdilution methods for the susceptibility testing of 10 systemically active antifungal agents when tested against Candida spp. , 2014, Diagnostic microbiology and infectious disease.

[11]  C. Pina-Vaz,et al.  Antibiofilm Effect of Cerium Nitrate against Bacteria and Yeast , 2013 .

[12]  M. Sachs,et al.  The Antidepressant Sertraline Provides a Promising Therapeutic Option for Neurotropic Cryptococcal Infections , 2012, Antimicrobial Agents and Chemotherapy.

[13]  S. Stepanović,et al.  Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[14]  T. Peláez,et al.  Fluconazole resistance mechanisms in Candida krusei: the contribution of efflux-pumps. , 2006, Medical mycology.

[15]  P. Mukherjee,et al.  Candida biofilm resistance. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[16]  S. Suh,et al.  Biofilm Production by Isolates of Candida Species Recovered from Nonneutropenic Patients: Comparison of Bloodstream Isolates with Isolates from Other Sources , 2002, Journal of Clinical Microbiology.

[17]  D. Fuchs,et al.  Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  C. Hiemke,et al.  Pharmacokinetics of selective serotonin reuptake inhibitors. , 2000, Pharmacology & therapeutics.

[19]  L. Tremaine,et al.  Metabolism and disposition of the 5-hydroxytryptamine uptake blocker sertraline in the rat and dog. , 1989, Drug metabolism and disposition: the biological fate of chemicals.